Tyrosine kinase inhibitor STI-571: the new wonder drug of cancer therapy

Cancer Biol Ther. 2004 Apr;3(4):393-4. doi: 10.4161/cbt.3.4.756. Epub 2004 Apr 12.

Authors

Rex C Haydon¹, Lan Zhou, Tong-Chuan He

Affiliation

¹ Molecular Oncology Laboratory, Department of Surgery, The University of Chicago Medical Center, Chicago, Illinois 60637, USA.

PMID: 15004535
DOI: 10.4161/cbt.3.4.756

No abstract available

Publication types

Comment

MeSH terms

Antineoplastic Agents / pharmacology*
Benzamides
Cell Transformation, Neoplastic
Chemoprevention
Colorectal Neoplasms / drug therapy
Colorectal Neoplasms / prevention & control
Drug Design
Humans
Imatinib Mesylate
Neoplasms / drug therapy
Piperazines / pharmacology*
Protein-Tyrosine Kinases / antagonists & inhibitors*
Pyrimidines / pharmacology*

Substances

Antineoplastic Agents
Benzamides
Piperazines
Pyrimidines
Imatinib Mesylate
Protein-Tyrosine Kinases